Cargando…

Evolution of Mutational Landscape and Tumor Immune-Microenvironment in Liver Oligo-Metastatic Colorectal Cancer

SIMPLE SUMMARY: About 10% of colorectal cancer patients presents with oligo-metastatic disease. The aim of our study was to assess genetic and immunologic dynamics underlying the oligo-metastatic status, evaluating genotype-phenotype correlations in a clean and homogeneous clinical model of liver-li...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ottaiano, Alessandro, Caraglia, Michele, Di Mauro, Annabella, Botti, Gerardo, Lombardi, Angela, Galon, Jerome, Luce, Amalia, D’Amore, Luigi, Perri, Francesco, Santorsola, Mariachiara, Hermitte, Fabienne, Savarese, Giovanni, Tatangelo, Fabiana, Granata, Vincenza, Izzo, Francesco, Belli, Andrea, Scala, Stefania, Delrio, Paolo, Circelli, Luisa, Nasti, Guglielmo
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7589866/ https://www.ncbi.nlm.nih.gov/pubmed/33096795 http://dx.doi.org/10.3390/cancers12103073

Ejemplares similares

KRAS Mutational Regression Is Associated With Oligo-Metastatic Status and Good Prognosis in Metastatic Colorectal Cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Genetic regressive trajectories in colorectal cancer: A new hallmark of oligo-metastatic disease?
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Oligo-Metastatic Cancers: Putative Biomarkers, Emerging Challenges and New Perspectives
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

BRAF p.V600E mutation as a molecular boundary between genuine oligo-repeated and poly-metastatic disease in colorectal cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Metastatic colorectal cancer and type 2 diabetes: prognostic and genetic interactions
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Genetic trajectory and immune microenvironment of lung-specific oligometastatic colorectal cancer
por: Ottaiano, Alessandro, et al.
Publicado: (2020)

Survival and Toxicities of Metastatic Colorectal Cancer Patients Treated with Regorafenib before TAS-102 or Vice Versa: A Mono-Institutional Real-Practice Study
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Prognostic Significance of CXCR4 in Colorectal Cancer: An Updated Meta-Analysis and Critical Appraisal
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Genetic landscape of colorectal cancer patients manifesting tumor shrinkage during SARS-Cov-2 infection
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Characterization of KRAS Mutational Regression in Oligometastatic Patients
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

KRAS p.G12C Mutation in Metastatic Colorectal Cancer: Prognostic Implications and Advancements in Targeted Therapies
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Hypertension, type 2 diabetes, obesity, and p53 mutations negatively correlate with metastatic colorectal cancer patients’ survival
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

A New Source of Heterogeneity in Comparative and Translational Clinical Trials: The “Border-Time” Bias
por: Santorsola, Mariachiara, et al.
Publicado: (2022)

Evolution of Treatment in Advanced Cholangiocarcinoma: Old and New towards Precision Oncology
por: Capuozzo, Maurizio, et al.
Publicado: (2022)

Prospective Evaluation of Radiotherapy-Induced Immunologic and Genetic Effects in Colorectal Cancer Oligo-Metastatic Patients with Lung-Limited Disease: The PRELUDE-1 Study
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

p53: From Fundamental Biology to Clinical Applications in Cancer
por: Capuozzo, Maurizio, et al.
Publicado: (2022)

Multifaceted Insights into Innovative Approaches to Treating Colorectal Cancer Metastasis: From Emerging Biological Factors to Radiomics
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Tumour Burden Reporting in Phase III Clinical Trials of Metastatic Lung, Breast, and Colorectal Cancers: A Systematic Review
por: Santorsola, Mariachiara, et al.
Publicado: (2022)

From Chaos to Opportunity: Decoding Cancer Heterogeneity for Enhanced Treatment Strategies
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Aflibercept or bevacizumab in combination with FOLFIRI as second-line treatment of mRAS metastatic colorectal cancer patients: the ARBITRATION study protocol
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

COVID-19 Outbreak: The North versus South Epidemiologic Italian Paradigm
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Clinical and Molecular Characteristics of Rare Malignant Tumors of Colon and Rectum
por: Ottaiano, Alessandro, et al.
Publicado: (2022)

Oligo-metastatic neoPlasms from the gastro-intestinal tract: iDentIfiCaTIon of cliNical and molecular drivers: the PREDICTION study
por: Ottaiano, Alessandro, et al.
Publicado: (2023)

Minimally invasive surgical treatment of intrahepatic cholangiocarcinoma: A systematic review
por: Patrone, Renato, et al.
Publicado: (2021)

Unexpected tumor reduction in metastatic colorectal cancer patients during SARS-Cov-2 infection
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

The safety and efficacy of Glubran 2 as biliostatic agent in liver resection
por: Patrone, Renato, et al.
Publicado: (2021)

Study of Ras Mutations’ Prognostic Value in Metastatic Colorectal Cancer: STORIA Analysis
por: Ottaiano, Alessandro, et al.
Publicado: (2020)

Impact of endobiliary radiofrequency ablation on survival of patients with unresectable cholangiocarcinoma: a narrative review
por: Di Girolamo, Elena, et al.
Publicado: (2023)

Magnetic Resonance Features of Liver Mucinous Colorectal Metastases: What the Radiologist Should Know
por: Granata, Vincenza, et al.
Publicado: (2022)

Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2022)

Correction: Conventional, functional and radiomics assessment for intrahepatic cholangiocarcinoma
por: Granata, Vincenza, et al.
Publicado: (2022)

Malignant Sinonasal Tumors: Update on Histological and Clinical Management
por: Bracigliano, Alessandra, et al.
Publicado: (2021)

The Tumor Dynamism Is the Dark Matter of the NGS Galaxy: How to Understand It?
por: Ottaiano, Alessandro, et al.
Publicado: (2021)

Circulating Tumor Cells as Predictive and Prognostic Biomarkers in Solid Tumors
por: Capuozzo, Maurizio, et al.
Publicado: (2023)

Updates on the Role of Molecular Alterations and NOTCH Signalling in the Development of Neuroendocrine Neoplasms
por: von Arx, Claudia, et al.
Publicado: (2019)

Organ Sparing for Locally Advanced Rectal Cancer after Neoadjuvant Treatment Followed by Electrochemotherapy
por: Rega, Daniela, et al.
Publicado: (2021)

Diagnostic performance of gadoxetic acid–enhanced liver MRI versus multidetector CT in the assessment of colorectal liver metastases compared to hepatic resection
por: Granata, Vincenza, et al.
Publicado: (2019)

Electrochemotherapy of Primary Colon Rectum Cancer and Local Recurrence: Case Report and Prospective Analysis
por: Rega, Daniela, et al.
Publicado: (2022)

EOB-MR Based Radiomics Analysis to Assess Clinical Outcomes following Liver Resection in Colorectal Liver Metastases
por: Granata, Vincenza, et al.
Publicado: (2022)

New CXCR4 Antagonist Peptide R (Pep R) Improves Standard Therapy in Colorectal Cancer
por: D’Alterio, Crescenzo, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_dlkcfhd6t34o11qk4sinv74a08